Clinical Ophthalmology.
People Policies Reception of articles Other

Hypothyroidism is an interdisciplinary problem

Abstract

DOI: 10.32364/2587-6821-2022-6-9-509-515

A.F. Verbovoy1, Yu.A. Dolgikh2, N.I. Verbovaya1

1“Center Diabetes", Samara, Russian Federation

2Samara State Medical University, Samara, Russian Federation

Hypothyroidism is one of the most prevalent endocrine disorders, second only to diabetes. Hypothyroidism diagnosis can be difficult in view of its varied and non-specific symptoms. The reason is that thyroid hormones affect virtually every organ system in the body. At the same time, the severity of thyroid hormone deficiency may vary and does not always correlate with the changes in laboratory testing results. Clinical presentation of patients with hypothyroidism may include multiple symptoms and, as a result, it can be difficult to diagnose this disorder, especially in elderly and polymorbid individuals. In some patients, the prevailing symptoms indicate that only a particular system is affected. Thus, there are diseases known as the "masks" of hypothyroidism, and this review is focused on their clinical manifestations. Conditions that may be running under the "mask" of hypothyroidism include diastolic hypertension, dyslipidemia, hydropericardium, chronic constipatio n, biliary lithiasis, polyarthritis, alopecia, onycholysis, depression, dysfunctional uterine bleeding, infertility, anemia, etc. Due to a variety of clinical signs and symptoms, a patient with hypothyroidism may get an appointment with any medical specialist or receive a follow-up care provided in parallel by multiple specialists. Physicians should be aware of potential hypothyroidism and specific effects of the underactive thyroid on patient’s organs and systems. It is necessary to obtain a thorough medical history about comorbidities which would help to figure out that hypothyroidism is the cause of co-occurring conditions.

Keywords: autoimmune thyroiditis, hypothyroidism, subclinical hypothyroidism, euthyroidism, dyslipidemia, cardiovascular diseases, arterial hypertension.

For citation: Verbovoy A.F., Dolgikh Yu.A., Verbovaya N.I. Hypothyroidism is an interdisciplinary problem. Russian Medical Inquiry. 2022;6(9):509–515 (in Russ.). DOI: 10.32364/2587-6821-2022-6-9-509-515.


Гипотиреоз — междисциплинарная проблема

About the authors:

Andrey F. Verbovoy — Dr. Sc. (Med.), Professor, Director of the "Center Diabetes"; 165, Samarskaya str., Samara, 443041, Russian Federation; ORCID iD 0000-0001-6123-5610.

Yuliya A. Dolgikh — C. Sc. (Med.), assistant, the Department of Endocrinology, Samara State Medical University; 89, Chapaevskaya str., Samara, 443099, Russian Federation; ORCID iD 0000-0001-6678-6411.

Nelly I. Verbovaya — Dr. Sc. (Med.), Professor, "Center Diabetes"; 165, Samarskaya str., Samara, 443041, Russian Federation.

Contact information: Andrey F. Verbovoy, е-mail: andreyy.verbovoyy@rambler.ru.

Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.

There is no conflict of interests.

Received 11.08.2022.

Revised 05.09.2022.

Accepted 28.09.2022.


References
1. Endocrinology: national guidelines. Dedov I.I., Melnichenko G.A., eds. M.: GEOTAR-Media; 2016 (in Russ.).
2. Redford C., Vaidya B. Subclinical hypothyroidism: Should we treat? Post Reprod Health. 2017;23(2):55–62. DOI: 10.1177/2053369117705058.
3. Fadeev V.V., Melnichenko G.A. Hypothyroidism: a guide for physicians. M.: RKI Sovero press; 2002 (in Russ.).
4. Sharma A.K., Arya R., Mehta R. et al. Hypothyroidism and cardiovascular disease: factors, mechanism and future perspectives. Curr Med Chem. 2013;20(35):4411–4418. DOI: 10.2174/09298673113206660255.
5. Duntas L.H., Chiovato L. Cardiovascular Risk in Patients with Subclinical Hypothyroidism. Eur Endocrinol. 2014;10(2):157–160. DOI: 10.17925/EE.2014.10.02.157.
6. Ro K., Yuen A.D., Du L. et al. Impact of Hypothyroidism and Heart Failure on Hospitalization Risk. Thyroid. 2018;28(9):1094–1100. DOI: 10.1089/thy.2017.0362.
7. Savchuk N.O., Kozhanova T.A., Gagarina A.A. et al. Features of the diurnal profile of blood pressure and heart rate variability in patients with arterial hypertension depending on the state of thyroid function. Tavricheskiy mediko-biologicheskiy vestnik. 2018;21(4):57–64 (in Russ.).
8. Kapralova I.Yu. Indexes of lipid pattern and functional status of myocardium in women with hypothyroidism. Endokrinologiya: novosti, mneniya, obuchenie. 2014;2(7):60–63 (in Russ.).
9. Nikolaeva A.V., Pimenov L.T., Dudarev M.V. Parameters of Lipidemia, Coronary Blood Flow and Global Longitudinal Strain of Myocardium in Patients with Subclinical Hypothyroidism in Combination with Stable Angina. Ateroskleroz i Dislipidemii. 2019;3(36):37–44 (in Russ.). DOI: 10.34687/2219-8202.JAD.2019.03.0005.
10. Raskina Ye.A., Sergeyev I.A., Feskova A.A., Perfilyeva M.V. Features of the course of arterial hypertension against the background of subclinical hypothyroidism. National health. 2018;2:143–149 (in Russ.).
11. Feskova A.A., Drobysheva Ye.S., Ovsyannikov Ye.S., Chernov A.V. Influence of subclinical hypofunction of the thyroid gland on the clinical course of hypertension. Prikladnyye informatsionnyye aspekty meditsiny. 2015;18(6):35–42 (in Russ.).
12. Nekrasova T.A., Strongin L.G., Morozova E.P. et al. Modifying influence of subclinical hypothyroidism on arterial hypertension: relationship to masked treatment failure, circadian blood pressure profile and target organs status. Clinical and experimental thyroidology. 2015;11(2):55–62 (in Russ.). DOI: 10.14341/ket2015255-62.
13. Kannan L., Shaw P.A., Morley M.P. et al. Thyroid Dysfunction in Heart Failure and Cardiovascular Outcomes. Circ Heart Fail. 2018;11(12):e005266. DOI: 10.1161/circheartfailure.118.005266.
14. Lillevang-Johansen M., Abrahamsen B., Jørgensen H.L. et al. Duration of over- and under-treatment of hypothyroidism is associated with increased cardiovascular risk. Eur J Endocrinol. 2019;180(6):407–416. DOI: 10.1530/eje-19-0006.
15. Ershova A.I., Al’ Rashi D.O., Ivanova A.A. et al. Secondary hyperlipidemias: etiology and pathogenesis. Russian Journal of Cardiology. 2019;24(5):74–81 (in Russ.). DOI: 10.15829/1560-4071-2019-5-74-81.
16. Budnevskiy A.V., Kravchenko A.Yа., Drobysheva Ye.S., Fes’kova A.A. Subclinical hypothyroidism as one of the causes of dyslipidemia. Klinicheskaya meditsina. 2015;93(1):13–17 (in Russ.).
17. Zhao M., Yang T., Chen L. et al. Subclinical hypothyroidism might worsen the effects of aging on serum lipid profiles: a population-based case-control study. Thyroid. 2015;25(5):485–493. DOI: 10.1089/thy.2014.0219.
18. Gong Y., Ma Y., Ye Z. et al. Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression. Metabolism. 2017;76:32–41. DOI: 10.1016/j.metabol.2017.07.006.
19. Fazaeli M., Khoshdel A., Shafiepour M., Rohban M. The influence of subclinical hypothyroidism on serum lipid profile, PCSK9 levels and CD36 expression on monocytes. Diabetes Metab Syndr. 2019;13(1):312–316. DOI: 10.1016/j.dsx.2018.08.021.
20. Rizos C.V., Elisaf M.S., Liberopoulos E.N. Effects of thyroid dysfunction on lipid profile. Open Cardiovasc Med J. 2011;5:76–84. DOI: 10.2174/1874192401105010076.
21. Zhao T., Chen B., Zhou Y. et al. Effect of levothyroxine on the progression of carotid intima-media thickness in subclinical hypothyroidism patients: a meta-analysis. BMJ Open. 2017;7:e016053. DOI: 10.1136/bmjopen-2017-016053.
22. Aziz M., Kandimalla Y., Machavarapu A. et al. Effect of thyroxin treatment on carotid intima-media thickness (CIMT) reduction in patients with subclinical hypothyroidism (SCH): a meta-analysis of clinical trials. J Atheroscler Thromb. 2017;24:643–659. DOI: 10.5551/jat.39917.
23. Delitala A.P., Filigheddu F., Orrù M. et al. No evidence of association between subclinical thyroid disorders and common carotid intima medial thickness or atherosclerotic plaque. Nutr Metab Cardiovasc Dis. 2015;25(12):1104–1110. DOI: 10.1016/j.numecd.2015.09.001.
24. Blum M.R., Gencer B., Adam L. et al. Impact of thyroid hormone therapy on atherosclerosis in the elderly with subclinical hypothyroidism: a randomized trial. J Clin Endocrinol Metab. 2018;103(8):2988–2997. DOI: 10.1210/jc.2018-00279.
25. Razvi S., Weaver J.U., Butler T.J. et al. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med. 2012;172(10):811–817. DOI: 10.1001/archinternmed.2012.1159.
26. Leng O., Razvi S. Hypothyroidism in the older population. Thyroid Res. 2019;12:2. DOI: 10.1186/s13044-019-0063-3.
27. Bathla M., Singh M., Relan P. Prevalence of anxiety and depressive symptoms among patients with hypothyroidism. Indian J Endocrinol Metab. 2016;20(4):468–474. DOI: 10.4103/2230-8210.183476.
28. Effraimidis G., Wiersinga W.M. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014;170(6):241–252. DOI: 10.1530/eje-14-0047.
29. Teplova L.V., Yeremeyeva A.V., Baykova O.A., Suvorova N.A. Rheumatic manifestations of hypothyroidism. Sovremennaya revmatologiya. 2017;11(2):47–53 (in Russ.). DOI: 10.14412/1996-7012-2017-2-47-53.
30. Radu L., Groppa L., Vudu L. Musculoskeletal impairment in primary hypothyroidism. Rev Med Chir Soc Med Nat Iasi. 2016;120(2):244–251. PMID: 27483700.
31. Muravyova G.V., Devlikamova F.I. Neuromuscular complications at thyroid diseases. Prakticheskaya meditsina. 2013;1(66):40–43 (in Russ.).
32. Kulagina T.I., Koryakova N.V., Rodionova O.A. et al. Severe depression and rhabdomyolysis as "masks" of primary hypothyroidism: clinical cases. Almanac of Clinical Medicine. 2019;47(2):186–194 (in Russ.). DOI: 10.18786/2072-0505-2019-47-012.
33. Romanenkova Yu.S., Kuzminova T.I., Kyzymko M.I. Differential diagnostics of neurological deficiency in case of hypothyroidism. International Research Journal. 2017;62(8–3):143–148 (in Russ.). DOI: 10.23670/IRJ.2017.62.058.
34. Petunina N.A., Truhina L.V., Martirosyan N.S., Petunina V.V. Injury of Various Organs and Body Systems During Hypothyroidism. Effektivnaya farmakoterapiya. 2016;4:40–44 (in Russ.).
35. Bathla M., Singh M., Relan P. Prevalence of anxiety and depressive symptoms among patients with hypothyroidism. Indian J Endocrinol Metab. 2016;20(4):468–474. DOI: 10.4103/2230-8210.183476.
36. Zhao T., Chen B.M., Zhao X.M., Shan Z.Y. Subclinical hypothyroidism and depression: a meta-analysis. Transl Psychiatry. 2018;8(1):239. DOI: 10.1038/s41398-018-0283-7.
37. Rao M., Zeng Z., Zhou F. et al. Effect of levothyroxine supplementation on pregnancy loss and preterm birth in women with subclinical hypothyroidism and thyroid autoimmunity: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(3):344–361. DOI: 10.1093/humupd/dmz003.
38. Nazarpour S., Ramezani Tehrani F., Simbar M. et al. Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. Eur J Endocrinol. 2017;176(2):253–265. DOI: 10.1530/EJE-16-0548.
39. Nazarpour S., Ramezani Tehrani F., Simbar M. et al. Effects of Levothyroxine on Pregnant Women With Subclinical Hypothyroidism, Negative for Thyroid Peroxidase Antibodies. J Clin Endocrinol Metab. 2018;103(3):926–935. DOI: 10.1210/jc.2017-01850.
40. Sidel’nikova V.M. Unintention of Pregnancy: A Guideт for Practicing Doctors. M.: MIA; 2010 (in Russ.).
41. Ilovaiskaya I.A. Hyperandrogenic disorders and diseases of women: differential diagnosis and therapeutic tactics. Doctor.Ru. 2018;150(6):49–55 (in Russ.). DOI: 10.31550/1727-2378-2018-150-6-49-55.
42. Khamoshina M.B. Topical issues of hyperprolactinemia in gynecological practice. Effektivnaya farmakoterapiya. 2010;5:76–78 (in Russ.).
43. La Vignera S., Vita R., Condorelli R.A. et al. Impact of thyroid disease on testicular function. Endocrine. 2017;58(3):397–407. DOI: 10.1007/s12020-017-1303-8.
44. Krytskyi T.I., Pasiechko N.V. Correlation of hypothyroidism and androgen deficiency in men of different periods of mature age. International Journal of Endocrinology. 2018;14(1):35–39 (in Russ.). DOI: 10.22141/2224-0721.14.1.2018.127089.
45. Vernigorodsky V.S., Vlasenko M.V., Palamarchuk A.V. et al Therapeutic masks of hypothyroidism. International Journal of Endocrinology. 2018;14(5):503–507 (in Russ.). DOI: 10.22141/2224-0721.14.5.2018.142688.
46. Nekrasova T.A., Strongin L.G., Ledentsova O.V. Hematological disturbances in subclinical hypothyroidism and their dynamics during substitution therapy. Klinicheskaya meditsina. 2013;9:29–33 (in Russ.).

License Creative Commons
This work is licensed under a Creative Commons «Attribution» 4.0 License.
Read the article in PDF in Russian


Previous article
Next article
Cardiometabolic characteristics of post-...
0
3972
Vitamin D deficiency in children with ob...
0
9118
All articles

Распечатать